2021

Take a break and read all about it

BIG and World Cancer Day – Together, all our actions matter

Monet St Juste 23 september 2022

OlympiA adjuvant trial results show olaparib for BRCA 1/2 mutated and high-risk early breast cancer reduced recurrence risk by 42%

Monet St Juste 23 september 2022

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

Monet St Juste 23 september 2022

Breast International Group’s new Executive Board

Monet St Juste 23 september 2022

First results of the European AURORA study: towards a better understanding of the molecular changes driving metastatic breast cancer

Monet St Juste 23 september 2022

Metastatic breast cancer, an ultramarathon

Monet St Juste 23 september 2022

First results of MA.32 trial: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals

Monet St Juste 23 september 2022

Do You Want To Boost Your Business?

drop us a line and keep in touch

Breast international group (BIG) – aisbl

Rue de bretagne 20,
1200 Brussels, Belgium
VAT BE 0468 176 240
IBAN BE08 0689 0916 0213

Navigation

The Breast International Group is proud to adhere
to the Code of Ethics of the VEF-AERF

© 2022 All rights reserved

Breast international group (BIG) - aisbl